ClariVest Asset Management’s NeoGenomics NEO Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | $459K | Hold |
33,119
| – | – | 0.05% | 356 |
|
|
2024
Q2 | $459K | Buy |
33,119
+40
| +0.1% | +$555 | 0.05% | 356 |
|
|
2024
Q1 | $520K | Buy |
33,079
+87
| +0.3% | +$1.37K | 0.05% | 356 |
|
|
2023
Q4 | $534K | Sell |
32,992
-5,800
| -15% | -$93.8K | 0.03% | 356 |
|
|
2023
Q3 | $477K | Sell |
38,792
-39,371
| -50% | -$484K | 0.03% | 347 |
|
|
2023
Q2 | $1.26M | Buy |
78,163
+45,296
| +138% | +$727K | 0.06% | 200 |
|
|
2023
Q1 | $573K | Buy |
32,867
+205
| +0.6% | +$3.57K | 0.03% | 364 |
|
|
2022
Q4 | $302K | Buy |
+32,662
| New | +$302K | 0.01% | 414 |
|
|
2021
Q4 | – | Sell |
-22,489
| Closed | -$1.09M | – | 784 |
|
|
2021
Q3 | $1.09M | Sell |
22,489
-904
| -4% | -$43.6K | 0.04% | 307 |
|
|
2021
Q2 | $1.06M | Buy |
23,393
+50
| +0.2% | +$2.26K | 0.04% | 283 |
|
|
2021
Q1 | $1.13M | Sell |
23,343
-1,400
| -6% | -$67.5K | 0.04% | 271 |
|
|
2020
Q4 | $1.33M | Sell |
24,743
-33,893
| -58% | -$1.82M | 0.05% | 241 |
|
|
2020
Q3 | $2.16M | Sell |
58,636
-2,637
| -4% | -$97.3K | 0.07% | 214 |
|
|
2020
Q2 | $1.9M | Sell |
61,273
-1,640
| -3% | -$50.8K | 0.05% | 237 |
|
|
2020
Q1 | $1.74M | Sell |
62,913
-364
| -0.6% | -$10K | 0.05% | 215 |
|
|
2019
Q4 | $1.85M | Sell |
63,277
-42,785
| -40% | -$1.25M | 0.04% | 253 |
|
|
2019
Q3 | $2.03M | Sell |
106,062
-5,817
| -5% | -$111K | 0.05% | 256 |
|
|
2019
Q2 | $2.46M | Sell |
111,879
-800
| -0.7% | -$17.6K | 0.06% | 227 |
|
|
2019
Q1 | $2.3M | Buy |
112,679
+83,695
| +289% | +$1.71M | 0.05% | 300 |
|
|
2018
Q4 | $365K | Buy |
+28,984
| New | +$365K | 0.01% | 483 |
|
|
2017
Q2 | – | Sell |
-89,000
| Closed | -$701K | – | 699 |
|
|
2017
Q1 | $701K | Buy |
89,000
+900
| +1% | +$7.09K | 0.02% | 365 |
|
|
2016
Q4 | $754K | Buy |
88,100
+6,800
| +8% | +$58.2K | 0.02% | 369 |
|
|
2016
Q3 | $668K | Buy |
81,300
+1,100
| +1% | +$9.04K | 0.02% | 352 |
|
|
2016
Q2 | $644K | Buy |
+80,200
| New | +$644K | 0.02% | 335 |
|